CircTHSD4 promotes the malignancy and docetaxel (DTX) resistance in prostate cancer by regulating miR-203/HMGA2 axis

Jianyun Xie1, Linjie Lu1, Jiali Zhang1

  • 1Department of Urology, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, China.

Oncology Research
|February 16, 2024
PubMed
Abstract

Insights

Circular RNA circTHSD4 promotes prostate cancer progression and docetaxel resistance by regulating the miR-203/HMGA2 pathway. Silencing circTHSD4 inhibits tumor growth and enhances drug sensitivity in prostate cancer models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) play a role in prostate cancer (PCa) progression and drug resistance.
  • circ_0005203 (circTHSD4) is a circRNA implicated in PCa malignancy and docetaxel (DTX) resistance.

Purpose of the Study:

  • To investigate the function of circTHSD4 in prostate cancer (PCa) malignancy and docetaxel (DTX) resistance.
  • To elucidate the underlying molecular mechanisms involving circTHSD4, miR-203, and HMGA2 in PCa.

Main Methods:

  • circTHSD4 expression was quantified using RT-qPCR in PCa tissues and cells.
  • Cellular assays (CCK-8, colony formation, Transwell, flow cytometry) and a xenograft mouse model were used to assess PCa cell malignancy and apoptosis.
  • Western blot and dual-luciferase reporter assays were employed to investigate the interaction between circTHSD4, miR-203, and HMGA2.

Main Results:

  • circTHSD4 was significantly upregulated in PCa tissues and cells, correlating with poor prognosis.
  • Silencing circTHSD4 suppressed PCa cell growth, migration, and colony formation, while increasing apoptosis.
  • circTHSD4 silencing enhanced docetaxel sensitivity and inhibited PCa carcinogenesis in vivo.
  • circTHSD4 was found to regulate HMGA2 expression by sponging miR-203.

Conclusions:

  • Overexpression of circTHSD4 promotes malignant phenotypes and docetaxel resistance in prostate cancer.
  • The circTHSD4/miR-203/HMGA2 axis is a key regulator of PCa progression and drug resistance.
  • circTHSD4 represents a potential therapeutic target for overcoming docetaxel resistance in prostate cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K